New Delhi: The Indian Council of Medical Research (ICMR) informed on Sunday that the third dose of Covaxin has been found to be promising protection against COVID.
Meanwhile, on Monday, the government is commencing the third or' precautionary' dose of the Covid-19 vaccine for healthcare-frontline workers and senior citizens with co-morbidities, as per its early announcement.
Highlighting the benefits, ICMR tweeted that the third dose of Covaxin holds its promise. They received reassuring information on safety and immunogenicity booster doses of Covaxin vaccinated six months after jabbing the first two doses of the same.
The tweet further said that trials detected good neutralising antibody titre against homologous and heterologous SARS-CoV 2 variants after administering the third. Reactogenicity in both vaccine and placebo subjects in the trial was minimal and comparable, while zero adverse events were reported.
Prime Minister Narendra Modi had announced on December 25 that vaccination for children of 15 to 18 age group would be commenced from January 3, and precautionary jabs for healthcare-frontline workers will be started on January 10.
Prime Minister's Office (PMO) then said that healthcare-frontline workers are given priority considering the exposure to the virus they could have while serving Covid-19 patients. The third dose will be called 'precautionary' rather than a booster.
This dose would strengthen the confidence of healthcare-frontline workers, PMO said. It further said that precaution dose would also be available for senior citizens aged above 60 with co-morbidities and in dire need of the dose as per their doctors.
According to the health ministry, with 89 lakh more jabs in the last 24 hours, India's Covid-19 vaccine coverage reached 151.58 crores on 7 am Monday.